Patent Assignment
Reel/Frame 050180/0339
Assignment of Assignor's Interest
Recorded: 2019-08-27
Pages: 6
Assignor
ZENITH CAPITAL CORP.
Executed: 2016-11-21
Assignee
ZENITH EPIGENETICS LTD.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Novel Quinazolinones as Bromodomain Inhibitors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 27, 2019
From: QUINN, JOHN FREDERICK; KHLEBNIKOV, VLADIMIR
To: RVX THERAPEUTICS INC.
Reel/Frame 050180/0219 →
General Conveyance and Assumption Agreement
Aug 27, 2019
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 050180/0309 →
Change of Name
Aug 27, 2019
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 050180/0326 →